title: Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B.
authors: R
authors: R
authors: Yang
authors: Y
authors: Y
authors: Zhao
authors: X
authors: X
authors: Wang
authors: J
authors: J
authors: Sun
authors: J
authors: J
authors: Jin
authors: D
authors: D
authors: Wu
authors: R
authors: R
authors: Charnigo
authors: A
authors: A
authors: O'Brien
authors: Z
authors: Z
authors: Zhong
authors: P
authors: P
authors: Rendo
mesh_terms: D000293:Adolescent; D000328:Adult; D044466:Asian People; D002648:Child; D002681:China; D005164:Factor IX / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D002836:Hemophilia B / Q000097:blood / Q000188:drug therapy*; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D011994:Recombinant Proteins; D005164:Factor IX